3 reports

The global antibody testing market was valued at US$ million 7,260.00 in 2021 and is projected to reach US$ 11,578.47 million by 2028; it is expected to grow at a CAGR of 6.9% from 2021 to 2028. The growth of the antibody testing market is mainly attributed to factors such as rising number of Covid-19 cases worldwide, increasing prevalence...

  • Infectious Disease
  • Autoimmune Disease
  • Endocrine Disease
  • World
  • APAC
  • Health Expenditure
  • Cause-Specific Mortality Rate

Abstract: - Global Rare Endocrine Disease Treatment Market to Reach $11.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Rare Endocrine Disease Treatment estimated at US$8.9 Billion in the year 2020, is projected to reach a revised size of US$11.5 Billion by 2027, growing at a CAGR of 3.6% over the...

  • Endocrine Disease
  • World
  • China
  • United States

A new research report of Persistence Market Research (PMR) delivers valuable intelligence on the global rare endocrine disease treatment market by providing an all-inclusive forecast on the market growth between the period 2017 and 2026.Addressing key concerns of drug makers for rare endocrine disease treatment, and reflecting impact of latest...

  • Endocrine Disease
  • World